American Society for Nutrition
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.6% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
De Novo Lipogenesis in Severity of NAFLD
Role: collaborator
Increasing Vegetable Intake Using Monosodium Glutamate: A Reduced-Effort Intervention
Role: collaborator
First Complementary Foods and the Infant Gastrointestinal Microbiota
Role: collaborator
Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults
Role: collaborator
Parent/Caregiver Conference Attendance Feasibility
Role: collaborator
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Role: collaborator
All 6 trials loaded